Non-Invasive Liquid Biopsy to Help Cancer Diagnosis Gets CE Ce...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
LONDON, March 11, 2021 /PRNewswire-AsiaNet/ -- Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformité Européenne (CE) Mark for its innovative TruBlood solution, a new paradigm in cancer detection, diagnosis and management.TruBlood is a blood-ba...
Authors: LATEST ASIANET NEWS RELEASES